JKB 119

an immunomodulatory and anti-inflammatory agent

Also Known As:

JKB-119; JKB119

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Liver Diseases (Liver Disease) 04/15/2011 - "Overall, these results suggest that JKB-119 can directly inhibit HSC activation attributed to anti-inflammatory activity and may, therefore, attenuate inflammation associated with HSC activation and liver disease."
2.	Inflammation (Inflammations) 04/15/2011 - "Overall, these results suggest that JKB-119 can directly inhibit HSC activation attributed to anti-inflammatory activity and may, therefore, attenuate inflammation associated with HSC activation and liver disease."